All changes for the tissue urogenital system (236)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA896
Vasodilation induced by acetylcholine or sodium reduced
Physiological
renal vasculature
Human
—
—
DAA898
Sodium conservation decreased
Physiological
renal tubule
Human
—
—
DAA2020
Reduction in renal function
Physiological
kidney
Human
—
—
DAA603
Prostate cancer
Pathological
prostate
Human
—
SeriesMorbidity
DAA600
Cervical cancer
Pathological
cervix
Human
—
SeriesMorbidity
DAA626
Essential (primary) hypertension and hypertensive renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA886
Renal arteriosclerosis
Pathological
renal vasculature
Human
—
—
DAA602
Ovarian cancer
Pathological
ovary
Human
—
SeriesMorbidity
DAA604
Cancer of kidney and renal pelvis
Pathological
urinary system
Human
—
SeriesMorbidity
DAA601
Cancer of corpus uteri and uterus, part unspecified
Pathological
uterus
Human
—
SeriesMorbidity
DAA599
Breast cancer
Pathological
mammary gland
Human
—
SeriesMorbidity
DAA640
Renal failure
Pathological
kidney
Human
—
SeriesMorbidity
DAA620
Hypertensive heart and renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA605
Bladder cancer
Pathological
bladder
Human
—
SeriesMorbidity
DAA639
Kidney diseases
Pathological
kidney
Human
—
SeriesMorbidity
DAA288
complement component 1, r subcomponent
Molecular
kidney
Human
C1R
21.0% Increase Gene Expression Level
DAA275
complement component 1, q subcomponent, C chain
Molecular
kidney
Human
C1QC
27.0% Increase Gene Expression Level
DAA281
coiled-coil domain containing 3
Molecular
kidney
Human
CCDC3
19.0% Increase Gene Expression Level
DAA263
claudin 8
Molecular
kidney
Human
CLDN8
17.0% Decrease Gene Expression Level
DAA2083
AT rich interactive domain 1A (SWI-like) increases with age
Molecular
ovary
Human
ARID1A
103.0% Increase Gene Expression Level
DAA267
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
Molecular
kidney
Human
APBB1IP
23.0% Increase Gene Expression Level
DAA2126
chromosome 4 open reading frame 34 decreases with age
Molecular
ovary
Human
SMIM14
35.9% Decrease Gene Expression Level
DAA291
chromosome 1 open reading frame 162
Molecular
kidney
Human
C1orf162
37.0% Increase Gene Expression Level
DAA2082
AT rich interactive domain 1A (SWI-like) increases with age
Molecular
ovary
Human
ARID1A
51.0% Increase Gene Expression Level
DAA2110
chromosome 12 open reading frame 35 increases with age
Molecular
ovary
Human
KIAA1551
71.0% Increase Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA896 | Vasodilation induced by acetylcholine or sodium reduced | Physiological | renal vasculature | Human | — | — | |
DAA898 | Sodium conservation decreased | Physiological | renal tubule | Human | — | — | |
DAA2020 | Reduction in renal function | Physiological | kidney | Human | — | — | |
DAA603 | Prostate cancer | Pathological | prostate | Human | — | SeriesMorbidity | |
DAA600 | Cervical cancer | Pathological | cervix | Human | — | SeriesMorbidity | |
DAA626 | Essential (primary) hypertension and hypertensive renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA886 | Renal arteriosclerosis | Pathological | renal vasculature | Human | — | — | |
DAA602 | Ovarian cancer | Pathological | ovary | Human | — | SeriesMorbidity | |
DAA604 | Cancer of kidney and renal pelvis | Pathological | urinary system | Human | — | SeriesMorbidity | |
DAA601 | Cancer of corpus uteri and uterus, part unspecified | Pathological | uterus | Human | — | SeriesMorbidity | |
DAA599 | Breast cancer | Pathological | mammary gland | Human | — | SeriesMorbidity | |
DAA640 | Renal failure | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA620 | Hypertensive heart and renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA605 | Bladder cancer | Pathological | bladder | Human | — | SeriesMorbidity | |
DAA639 | Kidney diseases | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA288 | complement component 1, r subcomponent | Molecular | kidney | Human | C1R | 21.0% Increase Gene Expression Level | |
DAA275 | complement component 1, q subcomponent, C chain | Molecular | kidney | Human | C1QC | 27.0% Increase Gene Expression Level | |
DAA281 | coiled-coil domain containing 3 | Molecular | kidney | Human | CCDC3 | 19.0% Increase Gene Expression Level | |
DAA263 | claudin 8 | Molecular | kidney | Human | CLDN8 | 17.0% Decrease Gene Expression Level | |
DAA2083 | AT rich interactive domain 1A (SWI-like) increases with age | Molecular | ovary | Human | ARID1A | 103.0% Increase Gene Expression Level | |
DAA267 | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | Molecular | kidney | Human | APBB1IP | 23.0% Increase Gene Expression Level | |
DAA2126 | chromosome 4 open reading frame 34 decreases with age | Molecular | ovary | Human | SMIM14 | 35.9% Decrease Gene Expression Level | |
DAA291 | chromosome 1 open reading frame 162 | Molecular | kidney | Human | C1orf162 | 37.0% Increase Gene Expression Level | |
DAA2082 | AT rich interactive domain 1A (SWI-like) increases with age | Molecular | ovary | Human | ARID1A | 51.0% Increase Gene Expression Level | |
DAA2110 | chromosome 12 open reading frame 35 increases with age | Molecular | ovary | Human | KIAA1551 | 71.0% Increase Gene Expression Level |